UNOPS supports the successful implementation of its
partners’ peacebuildin...
UNOPS supports the successful implementation of its
partners’ peacebuilding, humanitarian and development projects around the
world. Our mission is to serve people in need by expanding the ability of the
United Nations, governments and other partners to manage projects,
infrastructure and procurement in a sustainable and efficient manner.
Working in
some of the world’s most challenging environments, our vision is to advance
sustainable implementation practices, always satisfying or surpassing our
partners’ expectations.
With over
7,000 personnel spread across 80 countries, UNOPS offers its partners the
logistical, technical and management knowledge they need, wherever they need
it.
A flexible structure and global reach means that we can quickly respond
to our partners' needs, while offering the benefits of economies of
scale.
Stop TB Partnership
UNOPS hosts the Stop Tuberculosis Partnership Secretariat (STBP) as of 1 January 2015, in Geneva, Switzerland. The vision of the Stop TB Partnership is to realize the goal of elimination of Tuberculosis (TB) as a public health problem and, ultimately, to obtain a world free of TB by ensuring that every TB patient has access to effective diagnosis, treatment and cure; stopping transmission of TB; reducing the inequitable social and economic toll of TB; and developing and implementing new preventive, diagnostic and therapeutic tools and strategies. The Stop Partnership is uniquely positioned to support the development and further implementation by partners of the current and future Global Plan, acting as a coordinator and catalyst for the range of partners engaged in the fight against TB.
Founded in 2001, the Stop TB Partnership's mission is to serve every person who is vulnerable to TB and ensure that high-quality treatment is available to all who need it. Our partners include international and technical organizations, government programmes, research and funding agencies, foundations, NGOs, civil society and community groups and the private sector
An estimated one-third of the world’s total population has latent tuberculosis, a non-infectious and asymptomatic stage of the disease. Of these, about 15 percent develop active tuberculosis during their lifetime. Children under the age of five and people living with HIV are at much higher risk of developing active tuberculosis and are more likely to die from it.
As a key initiative of the STBP, the goal of the Global Drug Facility
(GDF) is to facilitate world-wide, equitable access to TB medicines and
diagnostics across both public and private sectors. This goal is achieved
through management and coordination of market activities for the full portfolio
of TB medicines and diagnostics, strategic procurement and innovative logistics
solutions, technical assistance and capacity building for TB programmes in
better pharmaceutical management practices, and accelerated uptake of new TB
medicines, regimens, and diagnostics using the GDF “launch pad”.